Feasibility and Accuracy of a Novel Xpert Cartridge
NCT02251327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 401
Last updated 2018-08-22
Summary
Consenting adults will be interviewed for demographic and medical information, and then will be asked to provide two expectorated sputum specimens. In the study laboratory, sputa will be tested using conventional and investigational diagnostic tests for tuberculosis.
Conditions
Interventions
- DEVICE
-
Investigational Xpert DST test
One investigational test performed directly on the same sputum specimen.
Sponsors & Collaborators
-
Boston Medical Center
collaborator OTHER - lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-04
- Primary Completion
- 2015-06-15
- Completion
- 2015-12-31
More Related Trials
-
Development of Molecular Diagnostic Platform for Tuberculosis
NCT04734236 ·Status: UNKNOWN ·Phase: NA
-
Development of a Rapid and Accurate Diagnostic Assay for Tuberculosis
NCT03423550 ·Status: UNKNOWN
-
Application of GeneXpert on Bronchoscopic Samples for Patients Suspicious of TB
NCT02838641 ·Status: COMPLETED
-
Effect of Xpert MTB/RIF on Patient Outcomes
NCT02729532 ·Status: COMPLETED
-
Acceptability and Feasibility of Home-based TB Testing
NCT04973371 ·Status: COMPLETED ·Phase: NA
-
Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons
NCT02538952 ·Status: COMPLETED ·Phase: PHASE4
-
Performance of Xpert MTB/RIF and XDR Assay for Diagnosis of Pulmonary Tuberculosis and Resistant Pulmonary TB
NCT06392594 ·Status: NOT_YET_RECRUITING
-
Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial Infection
NCT01150721 ·Status: COMPLETED
-
Development of Automated Molecular Diagnostic Platform for Tuberculosis Diagnosis (New Assay TB)
NCT04988984 ·Status: UNKNOWN
-
Global Consortium for Drug-resistant Tuberculosis Diagnostics
NCT02170441 ·Status: COMPLETED
-
Xpert MTB/Rif, a New Tool for the Diagnosis of Pulmonary Tuberculosis in Two Municipalities in Brazil
NCT01363765 ·Status: COMPLETED ·Phase: PHASE4
-
Xpert MTB/XDR Clinical Evaluation Trial
NCT03728725 ·Status: COMPLETED
-
Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations
NCT00134342 ·Status: COMPLETED
-
Assessing the Ability of the T-SPOT®.TB Test (IQ)
NCT03973970 ·Status: COMPLETED
-
Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease
NCT05981495 ·Status: UNKNOWN
-
Integrated Discovery and Development of Innovative TB Diagnostics
NCT06624501 ·Status: COMPLETED
-
Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis Suspects
NCT04074369 ·Status: UNKNOWN
-
Xpert MTB/RIF Test in the Diagnosis of Pulmonary Tuberculosis
NCT04433195 ·Status: UNKNOWN ·Phase: NA
-
Multidrug Resistance in Newly Diagnosed TB Patient
NCT06700577 ·Status: NOT_YET_RECRUITING
-
Improving TB Diagnosis and Treatment Through Basic, Applied and Health Systems Research
NCT03356925 ·Status: COMPLETED ·Phase: NA
-
DIAgnostics for Multidrug Resistant Tuberculosis in Africa
NCT03303963 ·Status: COMPLETED
-
TB-CAPT MTB/XDR Study
NCT04567368 ·Status: ACTIVE_NOT_RECRUITING
-
Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis
NCT02776150 ·Status: UNKNOWN
-
Assessing the Ability of the T-SPOT®.TB Test
NCT03929705 ·Status: COMPLETED
-
Bioaerosol Sampling in Suspected Pulmonary Tuberculosis
NCT04241809 ·Status: COMPLETED